Comparative effectiveness and safety of ribavirin plus interferon-alpha, lopinavir/ritonavir plus interferon-alpha, and ribavirin plus lopinavir/ritonavir plus interferon-alpha in patients with mild to moderate novel coronavirus disease 2019: study protocol.
- Author:
Yan-Ming ZENG
1
;
Xiao-Lei XU
1
;
Xiao-Qing HE
1
;
Sheng-Quan TANG
1
;
Yao LI
1
;
Yin-Qiu HUANG
2
;
Vijay HARYPURSAT
1
;
Yao-Kai CHEN
1
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Antiviral Agents; administration & dosage; Betacoronavirus; Coronavirus Infections; drug therapy; Drug Therapy, Combination; Humans; Interferon-alpha; administration & dosage; Lopinavir; administration & dosage; Middle Aged; Pandemics; Pneumonia, Viral; drug therapy; Randomized Controlled Trials as Topic; Ribavirin; administration & dosage; Ritonavir; administration & dosage
- From: Chinese Medical Journal 2020;133(9):1132-1134
- CountryChina
- Language:English
